Cancer u-turn reveals division in PMI
Bupa’s u-turn on capping cancer cover for its corporate schemes has exposed how fragmented the private medical insurance (PMI) industry is in its approach to the disease.
The healthcare giant claimed the recent policy reversal was an industry first and admitted that experience had shown that capping cancer cover left patients who claimed on their policies vulnerable at critical points in their treatment.
Bupa first removed cancer cover from its Select policy for schemes with more than 50 employees in November 2009 and, at the time, the insurer argued that the option gave customers choice.
Dr Natalie-Jane Macdonald, managing director, Bupa Health and Wellbeing
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.
You are currently unable to print this content. Please contact info@insuranceage.co.uk to find out more.
You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@insuranceage.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@insuranceage.co.uk